Market Research Logo

Biomar Microbial Technologies - Product Pipeline Review - 2016

Biomar Microbial Technologies - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Biomar Microbial Technologies - Product Pipeline Review - 2016’, provides an overview of the Biomar Microbial Technologies’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Biomar Microbial Technologies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Biomar Microbial Technologies
  • The report provides overview of Biomar Microbial Technologies including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Biomar Microbial Technologies’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Biomar Microbial Technologies’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Biomar Microbial Technologies’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Biomar Microbial Technologies
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Biomar Microbial Technologies’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Introduction
Global Markets Direct Report Coverage
Biomar Microbial Technologies Snapshot
Biomar Microbial Technologies Overview
Key Facts
Biomar Microbial Technologies - Research and Development Overview
Key Therapeutic Areas
Biomar Microbial Technologies - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Biomar Microbial Technologies - Pipeline Products Glance
Biomar Microbial Technologies - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Biomar Microbial Technologies - Drug Profiles
IB-05202 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-06202 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-07A037 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-07A081 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-07A085 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-08C175 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-08C179 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-09A0133 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-09A149 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-10A111 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-10C179 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IB-12A157 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule 1 for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule 2 for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule 3 for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules 4 for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Aspergillosis and Candidiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Glioblastoma - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Multi Drug Resistant Staphylococcus Aureus Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Neuropathic Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Tuberculosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize G-Protein-Coupled Receptors for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize VEGF Receptor for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Kinase for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit NIK for Multiple Sclerosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit tRNA for Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biomar Microbial Technologies - Pipeline Analysis
Biomar Microbial Technologies - Pipeline Products by Target
Biomar Microbial Technologies - Pipeline Products by Route of Administration
Biomar Microbial Technologies - Pipeline Products by Molecule Type
Biomar Microbial Technologies - Pipeline Products by Mechanism of Action
Biomar Microbial Technologies - Dormant Projects
Biomar Microbial Technologies - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Biomar Microbial Technologies, Key Facts
Biomar Microbial Technologies - Pipeline by Indication, 2016
Biomar Microbial Technologies - Pipeline by Stage of Development, 2016
Biomar Microbial Technologies - Monotherapy Products in Pipeline, 2016
Biomar Microbial Technologies - Preclinical, 2016
Biomar Microbial Technologies - Discovery, 2016
Biomar Microbial Technologies - Pipeline by Target, 2016
Biomar Microbial Technologies - Pipeline by Route of Administration, 2016
Biomar Microbial Technologies - Pipeline by Molecule Type, 2016
Biomar Microbial Technologies - Pipeline Products by Mechanism of Action, 2016
Biomar Microbial Technologies - Dormant Developmental Projects,2016
List of Figures
Biomar Microbial Technologies - Pipeline by Top 10 Indication, 2016
Biomar Microbial Technologies - Pipeline by Stage of Development, 2016
Biomar Microbial Technologies - Monotherapy Products in Pipeline, 2016
Biomar Microbial Technologies - Pipeline by Target, 2016
Biomar Microbial Technologies - Pipeline by Molecule Type, 2016
Biomar Microbial Technologies - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report